Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics

Trial Identifier: D1843R00351
Sponsor: AstraZeneca
NCTID:: NCT05953701
Start Date: July 2023
Primary Completion Date: September 2023
Study Completion Date: September 2023
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Koblenz, Germany